Novartis Inks Chinese mRNA-Therapy Deal for Up to $7.8 Billion
Novartis AG has entered into a licensing agreement with China's Abogen Biosciences for an mRNA-based autoimmune therapy. The deal is valued at up to $7.8 billion.
Novartis AG will license a messenger RNA-based autoimmune therapy from China’s Abogen Biosciences, in a deal worth as much as $7.8 billion.
READ NEXT
More on the wire
AI TLDR
Governor Kathy Hochul has appointed Attorney General Letitia James as a special prosecutor to handle the investigation into an alleged gang rape at a Cornell University fraternity.
AI TLDR
Tesla reported a decline in third-quarter vehicle sales compared to the previous year, attributed to the expiration of federal tax credits.
AI TLDR
A Texas mother allegedly killed her 4-year-old daughter and attempted suicide hours after losing a custody battle for the child.